Moderna began testing its COVID-19 vaccine, Spikevax, on March 16, 2020 — just a day after most U.S. states began implementing lockdown orders to prevent spread of the virus and a little over a month before Pfizer and BioNTech began a phase 1/2 trial of their vaccine.